ConductScience.org, home

Paper33529675

Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.

Rockey DC and 1 other. Gastroenterology, 2021. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside. Papers, record 33529675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33529675

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.
PubMed
Journal
Gastroenterology
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
7.15
iCite
Revised in PubMed
2023-11-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rockey DCDon C
2Friedman SLScott L

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
HepacivirusMajor topic
Hepatitis CMajor topic
LiverMajor topic
Liver CirrhosisMajor topic
Translational Research, BiomedicalMajor topic
Animals
Host-Pathogen Interactions
Humans
Liver Regeneration
Remission Induction
Treatment Outcome

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK056621NIDDK NIH HHSUnited StatesR01DK056621PubMed and NIHNIH RePORTER
P30 DK123704NIDDK NIH HHSUnited StatesP30DK123704PubMed and NIHNIH RePORTER
R01 DK098819NIDDK NIH HHSUnited StatesR01DK098819PubMed and NIHNIH RePORTER
P20 GM130457NIGMS NIH HHSUnited StatesP20GM130457PubMed and NIHNIH RePORTER
R01 DK128289NIDDK NIH HHSUnited StatesR01DK128289PubMed and NIHNIH RePORTER
R56 DK056621NIDDK NIH HHSUnited StatesR01DK056621PubMed and NIHNIH RePORTER
R01 DK113159NIDDK NIH HHSUnited StatesR01DK113159PubMed and NIHNIH RePORTER
R01 DK057830NIDDK NIH HHSUnited StatesR01DK057830PubMed and NIHNIH RePORTER
R56DK056621NIHNIH RePORTER

Download CSV of grants

References174

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120818376Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.Nat Med2010https://conductscience.org/library/papers/20818376PubMed
228960366Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.Hepatology2018https://conductscience.org/library/papers/28960366PubMed
330878469AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.Gastroenterology2019https://conductscience.org/library/papers/30878469PubMed
424265236Hepatic stellate cells and liver fibrosis.Compr Physiol2013https://conductscience.org/library/papers/24265236PubMed
523712051Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.J Hepatol2013https://conductscience.org/library/papers/23712051PubMed
628195349Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.Hepatology2017https://conductscience.org/library/papers/28195349PubMed
728585556Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.Am J Gastroenterol2017https://conductscience.org/library/papers/28585556PubMed
818376398Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone.Nat Biotechnol2008https://conductscience.org/library/papers/18376398PubMed
928734831Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.Gastroenterology2017https://conductscience.org/library/papers/28734831PubMed
1011738102Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.J Hepatol2001https://conductscience.org/library/papers/11738102PubMed
1128390144Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.Hepatology2017https://conductscience.org/library/papers/28390144PubMed
1227500382Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy.J Viral Hepat2016https://conductscience.org/library/papers/27500382PubMed
1328803953Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.J Hepatol2017https://conductscience.org/library/papers/28803953PubMed
1425500203KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.Gut2015https://conductscience.org/library/papers/25500203PubMed
1531654313Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.Dig Dis Sci2020https://conductscience.org/library/papers/31654313PubMed
1631122893Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.Lancet Respir Med2019https://conductscience.org/library/papers/31122893PubMed
1731849997Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.Front Immunol2019https://conductscience.org/library/papers/31849997PubMed
1830024770Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts.Am J Physiol Gastrointest Liver Physiol2018https://conductscience.org/library/papers/30024770PubMed
1927347680Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.PLoS One2016https://conductscience.org/library/papers/27347680PubMed
2012198653Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2.Hepatology2002https://conductscience.org/library/papers/12198653PubMed

See all 174 referencesDownload CSV of references

Cited by91

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
42942373Lower Plasma Brain-Derived Neurotrophic Factor Levels During Critical Illness Are Associated with Subsequent Dialysis Requirement.Medicina (Kaunas)2026https://conductscience.org/library/papers/42942373PubMed
42883939Cell Sheet Technology as a Platform for Functional Regeneration.Int J Mol Sci2026https://conductscience.org/library/papers/42883939PubMed
42725204Recurrent and De Novo Cirrhosis After Liver Transplantation.Portal Hypertens Cirrhosis2026https://conductscience.org/library/papers/42725204PubMed
42558794Ferroptosis in liver diseases: molecular mechanisms, biomarker potential, and clinical translation.Front Cell Dev Biol2026https://conductscience.org/library/papers/42558794PubMed
42417164Fibroblasts: a diverse population of cells balancing homeostasis, wound healing, regeneration, inflammation, fibrosis, and cancer across organs.JCI Insight2026https://conductscience.org/library/papers/42417164PubMed
42417159Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution.JCI Insight2026https://conductscience.org/library/papers/42417159PubMed
42218281Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma.Sci Rep2026https://conductscience.org/library/papers/42218281PubMed
42135704
Liver stiffness by non-invasive tests predicts hepatocellular carcinoma and liver-related complications following viral eradication with direct-acting antivirals in chronic hepatitis C: a retrospective cohort study.
BMC Gastroenterol2026https://conductscience.org/library/papers/42135704PubMed
41929481Hepatitis C virus core protein-induced myeloid-derived suppressor cells promote hepatic fibrosis by regulating hepatic stellate cell function via TGF-β.Front Immunol2026https://conductscience.org/library/papers/41929481PubMed
41629815Risk factors for significant hepatic fibrosis in alcoholic liver disease and construction of a nomogram prediction model.BMC Gastroenterol2026https://conductscience.org/library/papers/41629815PubMed
41601646Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.Front Immunol2025https://conductscience.org/library/papers/41601646PubMed
41594255Assessment of Liver Fibrosis Stage and Cirrhosis Regression After Long-Term Follow-Up Following Sustained Virological Response.Diagnostics (Basel)2026https://conductscience.org/library/papers/41594255PubMed
41459093Metabolic dysfunction and alcohol-associated liver disease (MetALD).eGastroenterology2025https://conductscience.org/library/papers/41459093PubMed
41368107Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study.World J Hepatol2025https://conductscience.org/library/papers/41368107PubMed
41327905Re-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerations.J Liver Cancer2026https://conductscience.org/library/papers/41327905PubMed
41303147Evolution of Liver Fibrosis in Romanian HCV Patients Following Treatment with Direct-Acting Antivirals.J Clin Med2025https://conductscience.org/library/papers/41303147PubMed
41301814Effect of Hepatitis C Virus Genotype, Cirrhosis, and Viral Cure on Serum Phosphatidylinositol Species Profiles.Biomedicines2025https://conductscience.org/library/papers/41301814PubMed
41236657Ablation for hepatocellular carcinoma in hepatitis B-related recompensated vs. compensated cirrhosis.Eur Radiol2026https://conductscience.org/library/papers/41236657PubMed
411267162025 KASL clinical practice guidelines for management of hepatitis C.Clin Mol Hepatol2026https://conductscience.org/library/papers/41126716PubMed
41096743Shared and Context-Specific Mechanisms of EMT and Cellular Plasticity in Cancer and Fibrotic Diseases.Int J Mol Sci2025https://conductscience.org/library/papers/41096743PubMed

See all 91 cited byDownload CSV of cited by

Genes24

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCR2729230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
CCR51234PubTator's text mininghttps://conductscience.org/library/genes/1234NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD24857124PubTator's text mininghttps://conductscience.org/library/genes/57124NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HNF4A3172PubTator's text mininghttps://conductscience.org/library/genes/3172NCBI Gene
IL113589PubTator's text mininghttps://conductscience.org/library/genes/3589NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
LOX4015PubTator's text mininghttps://conductscience.org/library/genes/4015NCBI Gene
LOXL24017PubTator's text mininghttps://conductscience.org/library/genes/4017NCBI Gene
MMP14312PubTator's text mininghttps://conductscience.org/library/genes/4312NCBI Gene
MMP144323PubTator's text mininghttps://conductscience.org/library/genes/4323NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
SERPINH1871PubTator's text mininghttps://conductscience.org/library/genes/871NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

See all 24 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33529675

GET https://conductscience.org/api/papers/v1/33529675/references?page=2